share_log

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

4:持股變動聲明-董事 Charles Faith L.
美股SEC公告 ·  11/21 05:33

牛牛AI助理已提取核心訊息

Charles Faith L., reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US) on November 18, 2024. The transaction involved the purchase of 75,000 shares of common stock, followed by an additional 266,594 shares at a price of $0.0919 per share. Following these transactions, Charles Faith L. now directly holds a total of 341,594 shares in the company. The transactions were classified as grants, awards, or other acquisitions, and have been completed as of the reported date.
Charles Faith L., reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US) on November 18, 2024. The transaction involved the purchase of 75,000 shares of common stock, followed by an additional 266,594 shares at a price of $0.0919 per share. Following these transactions, Charles Faith L. now directly holds a total of 341,594 shares in the company. The transactions were classified as grants, awards, or other acquisitions, and have been completed as of the reported date.
查爾斯·費斯·L.於2024年11月18日報告了對Conduit Pharmaceuticals (CDt.US)的重大股票收購。該交易涉及購買75,000股普通股,隨後又以每股0.0919美元的價格購買了266,594股。在這些交易完成後,查爾斯·費斯·L.現在直接持有該公司共計341,594股。交易被歸類爲贈與、獎勵或其他收購,並已在報告日期完成。
查爾斯·費斯·L.於2024年11月18日報告了對Conduit Pharmaceuticals (CDt.US)的重大股票收購。該交易涉及購買75,000股普通股,隨後又以每股0.0919美元的價格購買了266,594股。在這些交易完成後,查爾斯·費斯·L.現在直接持有該公司共計341,594股。交易被歸類爲贈與、獎勵或其他收購,並已在報告日期完成。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。